Cited by 6,597Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic DiseasesDiet, Metabolism, and Disease

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

Open access

Alberti, K. G. M. M., Zimmet, P., Shaw, J.·2006·Diabetic Medicine

DOI 10.1111/j.1464-5491.2006.01858.x

Open this paper in CoChat — free account Open PDF

Abstract

Aims To establish a unified working diagnostic tool for the metabolic syndrome (MetS) that is convenient to use in clinical practice and that can be used world‐wide so that data from different countries can be compared. An additional aim was to highlight areas where more research into the MetS is needed. Participants The International Diabetes Federation (IDF) convened a workshop held 12–14 May 2004 in London, UK. The 21 participants included experts in the fields of diabetes, public health, epidemiology, lipidology, genetics, metabolism, nutrition and cardiology. There were participants from each of the five continents as well as from the World Health Organization (WHO) and the National Cholesterol Education Program—Third Adult Treatment Panel (ATP III). The workshop was sponsored by an educational grant from AstraZeneca Pharmaceuticals. Consensus process The consensus statement emerged following detailed discussions at the IDF workshop. After the workshop, a writing group produced a consensus statement which was reviewed and approved by all participants. Conclusions The IDF has produced a new set of criteria for use both epidemiologically and in clinical practice world‐wide with the aim of identifying people with the MetS to clarify the nature of the syndrome and to focus therapeutic strategies to reduce the long‐term risk of cardiovascular disease. Guidance is included on how to compensate for differences in waist circumference and in regional adipose tissue distribution between different populations. The IDF has also produced recommendations for additional criteria that should be included when studying the MetS for research purposes. Finally, the IDF has identified areas where more studies are currently needed; these include research into the aetiology of the syndrome.

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2006.01858.x

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
Self-citation
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247
Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Self-citation
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
Pouliot, M., Després, J., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., & Lupien, P. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90676-9 · Cited by 2,099
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
Waist circumference as a measure for indicating need for weight management
Lean, M. E. J., Han, T. S., & Morrison, C. E. (1995) · BMJ · doi:10.1136/bmj.311.6998.158 · Cited by 1,869
The Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820
The Deadly Quartet
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,672
New Criteria for `Obesity Disease' in Japan
The Examination Committee of Criter (2002) · Circulation Journal · doi:10.1253/circj.66.987 · Cited by 1,650
Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance: The STOP-NIDDM Trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Haffner, S. M., Valdez, R. A., Hazuda, H. P., Mitchell, B. D., Morales, P. A., & D, M. P. S. M. (1992) · Diabetes · doi:10.2337/diab.41.6.715 · Cited by 1,234
Abdominal Adiposity and Coronary Heart Disease in Women
Rexrode, K. M. (1998) · JAMA · doi:10.1001/jama.280.21.1843 · Cited by 1,208
Adiponectin and Metabolic Syndrome
Matsuzawa, Y., Funahashi, T., Kihara, S., & Shimomura, I. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000099786.99623.ef · Cited by 1,203
The Influence of Body Fat Distribution on the Incidence of Diabetes Mellitus: 13.5 Years of Follow-up of the Participants in the Study of Men Born in 1913
Ohlson, L., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,143
Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women
Hu, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1066 · Cited by 1,135
The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
McNeill, A. M., Rosamond, W. D., Girman, C. J., Golden, S. H., Schmidt, M. I., East, H. E., Ballantyne, C. M., & HEISS, G. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.385 · Cited by 1,051
The metabolic syndrome: prevalence in worldwide populations
Cameron, A. J., Shaw, J. E., & Zimmet, P. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.005 · Cited by 1,031
Self-citation
The Public Health Impact of Obesity
Visscher, T. L. S., & Seidell, J. C. (2001) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.22.1.355 · Cited by 1,031
Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome
Carr, D. B., Utzschneider, K. M., Hull, R. L., Kodama, K., Retzlaff, B. M., Brunzell, J. D., Shofer, J. B., Fish, B. E., Knopp, R. H., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2087 · Cited by 993
Predictive Values of Body Mass Index and Waist Circumference for Risk Factors of Certain Related Diseases in Chinese Adults - Study on Optimal Cut-off Points of Body Mass Index and Waist Circumference in Chinese Adults
Zhou, Cooperative, B.-F., & on (2002) · 生物医学与环境科学：英文版 · Cited by 992
Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample
Han, T. S., Leer, E. M. V., Seidell, J. C., & Lean, M. E. J. (1995) · BMJ · doi:10.1136/bmj.311.7017.1401 · Cited by 974
Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort Study
Laaksonen, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf145 · Cited by 916
The Rising Prevalence of Diabetes and Impaired Glucose Tolerance
Dunstan, D. W., Zimmet, P., Welborn, T. A., de Courten, M., Cameron, A. J., Sicree, R. A., Dwyer, T., Colagiuri, S., Jolley, D., Knuiman, M. W., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.829 · Cited by 906
Self-citation
Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management
Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., & Participants, F. C. (2004) · Circulation · doi:10.1161/01.cir.0000112379.88385.67 · Cited by 864
The Deadly Quartet
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390070054005 · Cited by 842
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Bonora, E., Kiechl, S. J., Willeit, J., Oberhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R. C., & Muggeo, M. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1643 · Cited by 833
Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study
Carey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willet, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009158 · Cited by 827
Can We Apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians?
Tan, C. T., Ma, S., Wai, D. C. H., Chew, S. K., & Tai, E. S. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1182 · Cited by 824
The Metabolic Syndrome as Predictor of Type 2 Diabetes
Lorenzo, C., Okoloise, M., Williams, K., Stern, M. P., & Haffner, S. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3153 · Cited by 800
New Criteria for `Obesity Disease' in Japan
Oda, E. (2006) · Circulation Journal · doi:10.1253/circj.70.150 · Cited by 784
Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?
Stern, M. P., Williams, K., González-Villalpando, C., Hunt, K. J., & Haffner, S. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2676 · Cited by 735
Standards of Medical Care in Diabetes
(2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s15 · Cited by 688
National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study
Hunt, K. J., Resendez, R. G., Williams, K., Haffner, S. M., & Stern, M. P. (2004) · Circulation · doi:10.1161/01.cir.0000140762.04598.f9 · Cited by 662
Elevated C-Reactive Protein
Lemieux, I., Pascot, A., Prud’homme, D., Alméras, N., Bogaty, P. M., Nadeau, A., Bergeron, J., & Després, J. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.961 · Cited by 597
Cutoff Values for Normal Anthropometric Variables in Asian Indian Adults
Snehalatha, C., Viswanathan, V., & Ramachandran, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1380 · Cited by 546
Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.
Carr, M. C., & Brunzell, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0432 · Cited by 493
Body Weight and Mortality
Lee, I.-M. M. (1993) · JAMA · doi:10.1001/jama.1993.03510230061036 · Cited by 429
Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men
Nakamura, T., Tokunaga, K., Shimomura, I., Nishida, M., Yoshida, S., Kotani, K., Islam, A. H. M. W., Keno, Y., Kobatake, T., Nagai, Y., et al. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90025-6 · Cited by 429
Racial Differences in the Relation between Blood Pressure and Insulin Resistance
Saad, M. F., Lillioja, S., Nyomba, B. L., Castillo, C., Ferraro, R., De Gregorio, M., Ravussin, E., Knowler, W. C., Bennett, P. H., Howard, B. V., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241105 · Cited by 421
Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan
Lin, W.-Y., Lee, L.-T., Chen, C.-Y., Lo, H., Hsia, H.-H., Liu, I.-L., Lin, R.-S., Shau, W., & Huang, K.-C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802040 · Cited by 394
Insulin and Risk of Cardiovascular Disease
Ruige, J. B., Assendelft, W. J., Dekker, J. M., Kostense, P. J., Heine, R. J., & Bouter, L. M. (1998) · Circulation · doi:10.1161/01.cir.97.10.996 · Cited by 393
Race, Visceral Adipose Tissue, Plasma Lipids, and Lipoprotein Lipase Activity in Men and Women
Després, J., Couillard, C., Gagnon, J., Bergeron, J., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1932 · Cited by 387
Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin
the DECODA Study Group, & Nakagami, T. (2004) · Diabetologia · doi:10.1007/s00125-004-1334-6 · Cited by 334
Adipose tissue, insulin action and vascular disease: inflammatory signals
Yudkin, J. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802496 · Cited by 311
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol
Robins, S. J., Bloomfield, H. E., Faas, F. H., Schaefer, E. J., Elam, M. B., Anderson, J. W., Collins, D. E., & on behalf of the VA-HIT Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1513 · Cited by 308
The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study
Balkau, B., Vernay, M., Mhamdi, L., Novak, M., Arondel, D., Vol, S., Tichet, J., & Eschwège, É. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70067-8 · Cited by 268
Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults.
Wildman, R. P., Gu, D., Reynolds, K., Duan, X., & He, J. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1129 · Cited by 265
Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality
Anderson, P., Critchley, J. A. J. H., Chan, J., Cockram, C., Lee, Z. S. K., Thomas, G. N., & Tomlinson, B. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801837 · Cited by 239
A Dictionary of Epidemiology
Leger, A. S. S. (1996) · Journal of Epidemiology & Community Health · doi:10.1136/jech.50.2.229-b · Cited by 220
Cause-Specific Mortality in a Population With Diabetes
Roper, N. A., Bilous, R., Kelly, W. F., Unwin, N. C., & Connolly, V. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.43 · Cited by 179
The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives
Report prepared on behalf of the EGIR-RISC Study Group, Hills, S. A., Balkau, B., Coppack, S. W., Dekker, J. M., Mari, A., Natali, A., Walker, M., & Ferrannini, E. (2004) · Diabetologia · doi:10.1007/s00125-004-1335-5 · Cited by 177
Age and the Burden of Death Attributable to Diabetes in the United States
Saydah, S. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf111 · Cited by 173
Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status
Devaraj, S., Rosenson, R. S., & Jialal, I. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.008 · Cited by 146
Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population
Li, G.-H., Chen, X., Jang, Y., Wang, J., Xing, X., Yang, W., & Hu, Y. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00067.x · Cited by 134
Modification of the relationship between simple anthropometric indices and risk factors by ethnic background
Lear, S. A., Toma, M., Birmingham, C. L., & Frohlich, J. J. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00196-3 · Cited by 114
Endothelial dysfunction, inflammation, and insulin resistance: A focus on subjects at risk for type 2 diabetes
Caballero, A. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0074-9 · Cited by 114
Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance
Durbin, R. J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.0348.x · Cited by 108
Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project
Dobson, A. J., Evans, A., Ferrario, M., et al. (1998) · Annals of Medicine · doi:10.3109/07853899808999404 · Cited by 75
Cardiovascular risk, the metabolic syndrome and the hypertriglyceridaemic waist.
Underwood, P. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137237.97341.fd · Cited by 10
Untitled work
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7

Flagged first, then by citations

Research works printed but not linked: 8

Kylin E, 1923, Zentralblatt Fuer Innere Med, 44, 105
Vague J, 1947, Presse Medl, 53, 339
World Health Organization., 1999, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications.
American College of Endocrinology Task Force on the Insulin Resistance Syndrome., 2003, Endocr Pract, 9, 236
Nesto RW, 2003, Rev Cardiovasc Med, 4, S11
Zhou BF, 2002, Biomed Environ Sci, 15, 83
Balkau B, 2002, Diabet Metab, 28, 364
Cameron AJ, 2003, Atherosclerosis, 46, A3068

Sorted by citations

European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
The Metabolic Syndrome
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis
Harrison, S. A., Bedossa, P., Guy, C. D., Schattenberg, J. M., Loomba, R., Taub, R., Labriola, D., Moussa, S. E., Neff, G. W., Rinella, M. E., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2309000 · Cited by 2,084
The metabolic syndrome in children and adolescents ? an IDF consensus report
Zimmet, P., Alberti, K. G. M., Kaufman, F., Tajima, N., Silink, M., Arslanian, S., Wong, G., Bennett, P., Shaw, J., Caprio, S., et al. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00271.x · Cited by 2,013
Self-citation

See all 6,597

Authors: Alberti, K. G. M. M., Zimmet, P., & Shaw, J.
Affiliations: St Mary's Hospital (GB)
Corresponding author: Alberti, K. G. M. M.
ORCID: Zimmet, P.
Shaw, J.
Venue: Diabetic Medicine
Publisher: Wiley
Published: 2006-04-20
Volume: 23
Issue: 5
Pages: 469-480
ISSN: 0742-3071 (ISSN-L)
1464-5491
DOI: 10.1111/j.1464-5491.2006.01858.x
OpenAlex: W2130717716
Cited by: 6,597
References: 77
Citations by year: 2026: 227 · 2025: 319 · 2024: 371 · 2023: 375 · 2022: 360 · 2021: 420 · 2020: 406 · 2019: 338 · 2018: 370 · 2017: 347 · 2016: 317 · 2015: 346 · 2014: 402 · 2013: 369 · 2012: 334
FWCI: 151.02
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Diabetic Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Eli Lilly and Company
AstraZeneca
Novo Nordisk
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords: metabolic syndrome, diagnostic criteria, International Diabetes Federation, consensus statement, waist circumference, body fat distribution, cardiovascular risk
MeSH terms: Adipose Tissue, Adult, Female, Humans, Hypertension, Insulin Resistance, International Cooperation, Male, Obesity, Societies, Medical, Metabolic Syndrome, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks